A true splenic cyst producing carbohydrate antigen 19-9 and cancer antigens 50 and 125, but not interleukin 10

Digestive Surgery

Volumn 20, Issue 1, 2003, Pages 71-74

  Galizia, Gennaro ^a   Lieto, Eva ^a   Ferraraccio, Francesca ^a   Castellano, Paolo ^a   De Vita, Ferdinando ^a   Orditura, Michele ^a   Romano, Ciro ^a   Pignatelli, Carlo ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

Author keywords

Carbohydrate antigen 19 9; Interleukin 10; True splenic cysts; Tumour markers

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; INTERLEUKIN 10; TUMOR ANTIGEN; TUMOR MARKER;

ABDOMINAL INJURY; ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DISEASE COURSE; ECHOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LABORATORY TEST; LAPAROTOMY; OVARIECTOMY; OVARY CYST; POSTOPERATIVE PERIOD; PREDICTION; SPLEEN CYST; SURGICAL TECHNIQUE; TISSUE TYPES;

ADULT; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CYSTS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-10; OVARIAN CYSTS; OVARIECTOMY; SPLENECTOMY; SPLENIC DISEASES;

EID: 0037234872     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000068858     Document Type: Article

References (23)

1. Lopez JB, Royan GP, Lakhwani MN, Mahadaven M, Timor J: CA 72-4 compared with CEA and CA 19-9 as a marker of some gastrointestinal malignancies. Int J Biol Markers 1999;14:172-177.
2. Mann DV, Edwards R, Ho S, Lau WY, Glazer G: Elevated tumour marker CA19-9: Clinical interpretation and influence of obstructive jaundice. Eur J Surg Oncol 2000;26:474-479.
3. Halm U, Schumann T, Schiefke I, Witzigmann H, Mossner J, Keim V: Decrease of CA 19-9 during chemotherapy with gemcitabine predicts survival time in patients with advanced pancreatic cancer. Br J Cancer 2000;82:1013-1016.
4. Ito S, Gejyo F: Elevation of serum CA19-9 levels in benign diseases. Intern Med 1999;38:840-841.
5. Kim HJ, Kim MH, Myung SJ, Lim BC, Park ET, Yoo KS, Seo DW, Lee SK, Min YI: A new strategy for the application of CA19-9 in the differentiation of pancreaticobiliary cancer: Analysis using a receiver operating characteristic curve. Am J Gastroenterol 1999;94:1941-1946.
6. Terada T, Yasoshima M, Yoshimitsu Y, Nakanuma Y: Carbohydrate antigen 19-9 producing giant epithelial cyst of the spleen in a young woman. J Clin Gastroenterol 1994;18:57-61.
7. Walz MK, Metz KA, Sastry M, Eigler FW, Leder LD: Benign mesothelial splenic cyst may cause high serum concentration of CA 19-9. Eur J Surg 1994;160:389-391.
8. Yoshikane H, Suzuki T, Yoshioka N, Ogawa Y, Hayashi Y, Hamajima E, Yokoi T: Giant splenic cyst with high serum concentration of CA 19-9: Failure of treatment with percutaneous transcatheter drainage and injection of tetracycline. Scand J Gastroenterol 1996;31:524-526.
9. Decker D, Bollmann R, Hirner A, Stratmann H: Increased CA-19-9 caused by a splenic cyst: A rare differential diagnosis. Zentralbl Chir 1998;123: 855-857.
10. Higaki K, Jimi A, Watanabe J, Kusaba A, Kojiro M: Epidermoid cyst of the spleen with CA19-9 or carcinoembryonic antigen productions: Report of three cases. Am J Surg Pathol 1998;22:704-708.
11. Sardi A, Ojeda HF, King D Jr: Laparoscopic resection of a benign true cyst of the spleen with the harmonic scalpel producing high levels of CA 19-9 and carcinoembryonic antigen. Am Surg 1998;64:1149-1154.
12. Ishibashi R, Sakai T, Yamashita Y, Maekawa T, Hideshima T, Shirakusa T: Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9. Int Surg 1999;84:151-154.
13. Sakamoto Y, Yunotani S, Edakuni G, Mori M, Iyama A, Miyazaki K: Laparoscopic splenectomy for a giant splenic epidermoid cyst: Report of a case. Surg Today 1999;29:1268-1272.
14. van Lacum MW, Hessels RA, Kremer GD, Jaspers CA: A splenic cyst and a high serum CA 19-9: A case report. Eur J Intern Med 2000;11:104-107.
15. Soudack M, Ben-Nun A, Toledano C: Elevated carbohydrate antigen 19-9 in patients with true (epithelial) splenic cysts rare or undiscovered? Can J Gastroenterol 2001;15:125-126.
16. McLaughlin R, O'Hanlon D, Kerin M, Kenny P, Grimes H, Given HF: Are elevated levels of the tumour marker CA19-9 of any clinical significance? An evaluation. Ir J Med Sci 1999;168:124-126.
17. De Vita F, Orditura M, Galizia G, Romano C, Lieto E, Iodice P, Tuccillo C, Catalano G: Serum interleukin-10 is an independent prognostic factor in advanced solid tumors. Oncol Rep 2000;7:357-361.
18. De Vita F, Orditura M, Galizia G, Romano C, Infusino S, Auriemma A, Lieto E, Catalano G: Serum interleukin-10 levels in patients with advanced gastrointestinal malignancies. Cancer 1999;86:1936-1943.
19. Sternberger LA, Sternberger NH: The unlabeled antibody method: Comparison of peroxidase-antiperoxidase with avidin-biotin complex by a new method of quantification. J Histochem Cytochem 1986;34:599-605.
20. Williams RJ, Glazer G: Splenic cysts: Changes in diagnosis, treatment and aetiological concepts. Ann R Coll Surg Engl 1993;75:87-89.
21. de Melo VA, Alves Junior A, Andrade LC, Aragao JF, Rosa JE: Splenic cyst: Review of the literature and report of 2 cases. Rev Hosp Clin Fac Med São Paulo 1995;50:289-293.
22. Rohr S, Trombetta V, Maloisel F, Becmeur F, Chenard MP, Meyer C: True benign non-parasitic cysts of the spleen: From diagnosis to treatment. A propos of 5 new cases. J Chir (Paris) 1995;132:467-471.
23. Seshadri PA, Poulin EC, Mamazza J, Schlachta CM: Needlescopic decapsulation of a splenic epithelial cyst. Can J Surg 2000;43:303-305.